GSK's chief executive, Emma Walmsley, accentuated the group's pipeline in comments on the results, pointing to "11 positive phase 3 trials reported so far this year and [...planned] launches for ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...

The abrupt termination of critical USAID-funded clinical trials, with insufficient time to safeguard the welfare of people who are participating, is profoundly unethical and utterly inexcusable.

Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

The FDA approved GSK’s pentavalent meningococcal vaccine to protect children and young adults aged 10 to 25 years against ...

Now, GSK is ready to play catch-up after nabbing ... Committee on Immunization Practices (ACIP) has issued a shared clinical decision-making recommendation for MenB vaccines.

NEW YORK, NY / ACCESS Newswire / February 15, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Receipts ("ADRs") of GSK plc (NYSE ...

Feb 15 (Reuters) - The U.S. Food and Drug Administration approved British drugmaker GSK's (GSK.L), opens new tab combination vaccine to protect against meningococcal infection for use in people ...

Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research ... dividend growth mean the yields on GSK’s shares soar above the FTSE 100 ...

This discipline includes fundamental research on the biochemistry, physiology, cell biology, ecology, evolution and clinical aspects of microorganisms, including the host response to these agents.